Literature DB >> 17404883

Cannabinoid CB(1) receptor and gastric acid secretion.

Francesca Borrelli.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17404883     DOI: 10.1007/s10620-006-9507-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  6 in total

Review 1.  The gastrointestinal pharmacology of cannabinoids.

Authors:  A A Izzo; N Mascolo; F Capasso
Journal:  Curr Opin Pharmacol       Date:  2001-12       Impact factor: 5.547

Review 2.  Obesity drugs in clinical development.

Authors:  Jason C G Halford
Journal:  Curr Opin Investig Drugs       Date:  2006-04

3.  Metabolic risk factors, drugs, and obesity.

Authors:  Raj Padwal; Sumit Majumdar
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

4.  Neurogenic stimulation of gastric acid secretion by the Na+, K(+)-ATPase inhibitor ouabain in mouse isolated stomach.

Authors:  S Horie; T Maruyama; S Yano; K Watanabe
Journal:  Gen Pharmacol       Date:  1996-07

Review 5.  The gastrointestinal pharmacology of cannabinoids: an update.

Authors:  Angela A Coutts; Angelo A Izzo
Journal:  Curr Opin Pharmacol       Date:  2004-12       Impact factor: 5.547

6.  Effects of cannabinoid receptor agonists on rat gastric acid secretion: discrepancy between in vitro and in vivo data.

Authors:  Gabriella Coruzzi; Maristella Adami; Elena Guaita; Alessandro Menozzi; Simone Bertini; Elena Giovannini; Giulio Soldani
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

  6 in total
  1 in total

Review 1.  Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716).

Authors:  Hester van Diepen; Eberhard Schlicker; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-25       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.